Dr. Zhi Peng is a senior expert in gastrointestinal oncology in China, with profound expertise in the comprehensive and individualized management of gastrointestinal malignancies. He has long focused on the systemic treatment and multidisciplinary management of gastric cancer, colorectal cancer, and esophageal cancer. Dr. Peng advocates for a multidisciplinary team (MDT) approach and emphasizes precision and individualized treatment planning, integrating cutting-edge research findings with clinical practice to deliver effective, low-toxicity, full-course cancer care.
Dr. Peng has led multiple national research projects and achieved significant results in the molecular subtyping, translational research, and drug-resistance mechanism studies of advanced gastric and colorectal cancers. His work has contributed to the optimization and updating of several clinical practice guidelines. He has received numerous prestigious awards, including the First Prize of the Chinese Medical Science and Technology Award, the Chinese Anti-Cancer Association Young Scientist Award, and the First Prize of the Chinese Anti-Cancer Association Science and Technology Award. In addition to his clinical and research achievements, he is actively involved in medical education and public science communication, contributing to the advancement of standardized gastrointestinal cancer care in China.
